{
  "question": "Which of the following anti-tubercular drug is avoided in a HIV positive patient on zidovudine, lamivudine and indinavir therapy who develops TB?",
  "is_multi_choice": true,
  "correct_answer": "opd",
  "options": {
    "opa": "Pyrazinamide",
    "opb": "Isoniazid",
    "opc": "Ethambutol",
    "opd": "Rifampicin"
  },
  "topic_name": "Pharmacology",
  "context": null,
  "initial_causal_graph": {
    "nodes": [],
    "relationships": [],
    "paths": []
  },
  "causal_graph": {
    "nodes": [
      [
        "Zidovudine",
        "Tuberculosis"
      ],
      [
        "Indinavir",
        "Tuberculosis"
      ],
      [
        "Lamivudine",
        "Tuberculosis"
      ],
      [
        "Zidovudine",
        "Tuberculosis"
      ],
      [
        "Indinavir",
        "Tuberculosis"
      ],
      [
        "Lamivudine",
        "Tuberculosis"
      ],
      [
        "Zidovudine",
        "Tuberculosis"
      ],
      [
        "Indinavir",
        "Tuberculosis"
      ],
      [
        "Lamivudine",
        "Tuberculosis"
      ],
      [
        "Cytochrome P450",
        "Adverse effects",
        "Disease",
        "Drug Interactions"
      ],
      [
        "Cytochrome P450",
        "Exhaustion",
        "Disease",
        "Drug Interactions"
      ],
      [
        "Zidovudine",
        "Tuberculosis"
      ],
      [
        "Indinavir",
        "Tuberculosis"
      ],
      [
        "Lamivudine",
        "Tuberculosis"
      ],
      [
        "Zidovudine",
        "Tuberculosis"
      ],
      [
        "Indinavir",
        "Tuberculosis"
      ],
      [
        "Lamivudine",
        "Tuberculosis"
      ],
      [
        "Zidovudine",
        "Tuberculosis"
      ],
      [
        "Indinavir",
        "Tuberculosis"
      ],
      [
        "Lamivudine",
        "Tuberculosis"
      ]
    ],
    "relationships": [
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "PREVENTS",
        "CAUSES",
        "CAUSES"
      ],
      [
        "CAUSES",
        "MANIFESTATION_OF",
        "CAUSES"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ],
      [
        "TREATS"
      ]
    ],
    "paths": [
      "(Zidovudine)-TREATS->(Tuberculosis)",
      "(Indinavir)-TREATS->(Tuberculosis)",
      "(Lamivudine)-TREATS->(Tuberculosis)",
      "(Zidovudine)-TREATS->(Tuberculosis)",
      "(Indinavir)-TREATS->(Tuberculosis)",
      "(Lamivudine)-TREATS->(Tuberculosis)",
      "(Zidovudine)-TREATS->(Tuberculosis)",
      "(Indinavir)-TREATS->(Tuberculosis)",
      "(Lamivudine)-TREATS->(Tuberculosis)",
      "(Cytochrome P450)-PREVENTS->(Adverse effects)-CAUSES->(Disease)-CAUSES->(Drug Interactions)",
      "(Cytochrome P450)-CAUSES->(Exhaustion)-MANIFESTATION_OF->(Disease)-CAUSES->(Drug Interactions)",
      "(Zidovudine)-TREATS->(Tuberculosis)",
      "(Indinavir)-TREATS->(Tuberculosis)",
      "(Lamivudine)-TREATS->(Tuberculosis)",
      "(Zidovudine)-TREATS->(Tuberculosis)",
      "(Indinavir)-TREATS->(Tuberculosis)",
      "(Lamivudine)-TREATS->(Tuberculosis)",
      "(Zidovudine)-TREATS->(Tuberculosis)",
      "(Indinavir)-TREATS->(Tuberculosis)",
      "(Lamivudine)-TREATS->(Tuberculosis)"
    ]
  },
  "knowledge_graph": {
    "nodes": [
      [
        "HIV",
        "Lipopolysaccharides",
        "Zidovudine"
      ],
      [
        "HIV",
        "Retroviridae",
        "Zidovudine"
      ],
      [
        "Indinavir",
        "Pharmaceutical Preparations",
        "Genes",
        "Blood",
        "HIV therapy"
      ],
      [
        "Indinavir",
        "Inflammation",
        "Genes",
        "Blood",
        "HIV therapy"
      ],
      [
        "HIV",
        "Lipopolysaccharides",
        "Zidovudine"
      ],
      [
        "HIV",
        "Retroviridae",
        "Zidovudine"
      ],
      [
        "Cytochrome P450",
        "Pharmaceutical Preparations",
        "Zidovudine"
      ],
      [
        "Cytochrome P450",
        "Pharmaceutical Preparations",
        "Zidovudine"
      ],
      [
        "Zidovudine",
        "Cells",
        "Blood",
        "HIV therapy"
      ],
      [
        "Zidovudine",
        "Cell Line",
        "Blood",
        "HIV therapy"
      ],
      [
        "HIV",
        "Lipopolysaccharides",
        "Zidovudine"
      ],
      [
        "HIV",
        "Retroviridae",
        "Zidovudine"
      ],
      [
        "HIV",
        "Lipopolysaccharides",
        "Zidovudine"
      ],
      [
        "HIV",
        "Retroviridae",
        "Zidovudine"
      ],
      [
        "HIV",
        "Lipopolysaccharides",
        "Zidovudine"
      ],
      [
        "HIV",
        "Retroviridae",
        "Zidovudine"
      ],
      [
        "HIV",
        "Lipopolysaccharides",
        "Zidovudine"
      ],
      [
        "HIV",
        "Retroviridae",
        "Zidovudine"
      ]
    ],
    "relationships": [
      [
        "LOCATION_OF",
        "INTERACTS_WITH"
      ],
      [
        "ISA",
        "LOCATION_OF"
      ],
      [
        "ISA",
        "INTERACTS_WITH",
        "PART_OF",
        "LOCATION_OF"
      ],
      [
        "TREATS",
        "ASSOCIATED_WITH",
        "PART_OF",
        "LOCATION_OF"
      ],
      [
        "LOCATION_OF",
        "INTERACTS_WITH"
      ],
      [
        "ISA",
        "LOCATION_OF"
      ],
      [
        "ISA",
        "INTERACTS_WITH"
      ],
      [
        "INTERACTS_WITH",
        "INTERACTS_WITH"
      ],
      [
        "PART_OF",
        "PART_OF",
        "LOCATION_OF"
      ],
      [
        "PART_OF",
        "PART_OF",
        "LOCATION_OF"
      ],
      [
        "LOCATION_OF",
        "INTERACTS_WITH"
      ],
      [
        "ISA",
        "LOCATION_OF"
      ],
      [
        "LOCATION_OF",
        "INTERACTS_WITH"
      ],
      [
        "ISA",
        "LOCATION_OF"
      ],
      [
        "LOCATION_OF",
        "INTERACTS_WITH"
      ],
      [
        "ISA",
        "LOCATION_OF"
      ],
      [
        "LOCATION_OF",
        "INTERACTS_WITH"
      ],
      [
        "ISA",
        "LOCATION_OF"
      ]
    ],
    "paths": [
      "(HIV)-LOCATION_OF->(Lipopolysaccharides)-INTERACTS_WITH->(Zidovudine)",
      "(HIV)-ISA->(Retroviridae)-LOCATION_OF->(Zidovudine)",
      "(Indinavir)-ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Genes)-PART_OF->(Blood)-LOCATION_OF->(HIV therapy)",
      "(Indinavir)-TREATS->(Inflammation)-ASSOCIATED_WITH->(Genes)-PART_OF->(Blood)-LOCATION_OF->(HIV therapy)",
      "(HIV)-LOCATION_OF->(Lipopolysaccharides)-INTERACTS_WITH->(Zidovudine)",
      "(HIV)-ISA->(Retroviridae)-LOCATION_OF->(Zidovudine)",
      "(Cytochrome P450)-ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Zidovudine)",
      "(Cytochrome P450)-INTERACTS_WITH->(Pharmaceutical Preparations)-INTERACTS_WITH->(Zidovudine)",
      "(Zidovudine)-PART_OF->(Cells)-PART_OF->(Blood)-LOCATION_OF->(HIV therapy)",
      "(Zidovudine)-PART_OF->(Cell Line)-PART_OF->(Blood)-LOCATION_OF->(HIV therapy)",
      "(HIV)-LOCATION_OF->(Lipopolysaccharides)-INTERACTS_WITH->(Zidovudine)",
      "(HIV)-ISA->(Retroviridae)-LOCATION_OF->(Zidovudine)",
      "(HIV)-LOCATION_OF->(Lipopolysaccharides)-INTERACTS_WITH->(Zidovudine)",
      "(HIV)-ISA->(Retroviridae)-LOCATION_OF->(Zidovudine)",
      "(HIV)-LOCATION_OF->(Lipopolysaccharides)-INTERACTS_WITH->(Zidovudine)",
      "(HIV)-ISA->(Retroviridae)-LOCATION_OF->(Zidovudine)",
      "(HIV)-LOCATION_OF->(Lipopolysaccharides)-INTERACTS_WITH->(Zidovudine)",
      "(HIV)-ISA->(Retroviridae)-LOCATION_OF->(Zidovudine)"
    ]
  },
  "enhanced_graph": {
    "nodes": [],
    "relationships": [],
    "paths": [
      "(HIV)-LOCATION_OF->(Lipopolysaccharides)-INTERACTS_WITH->(Zidovudine)",
      "(Zidovudine)-TREATS->(Tuberculosis)",
      "(Lamivudine)-TREATS->(Tuberculosis)",
      "(HIV)-ISA->(Retroviridae)-LOCATION_OF->(Zidovudine)",
      "(Indinavir)-TREATS->(Tuberculosis)",
      "(Cytochrome P450)-INTERACTS_WITH/ISA->(Pharmaceutical Preparations)-INTERACTS_WITH->(Zidovudine)",
      "(Zidovudine)-PART_OF->(Cells)-PART_OF->(Blood)-LOCATION_OF->(HIV therapy)"
    ]
  },
  "reasoning_chain": [
    "CHAIN: \"HIV positive patient\" -> \"on zidovudine, lamivudine, indinavir\" -> \"develops TB\" -> \"consider anti-tubercular drugs\" -> \"Rifampicin\" -> \"induces cytochrome P450\" -> \"decreases indinavir levels\" -> \"reduced efficacy of HIV therapy\" -> 95%",
    "CHAIN: \"HIV positive patient\" -> \"on zidovudine, lamivudine, indinavir\" -> \"develops TB\" -> \"consider anti-tubercular drugs\" -> \"Rifampicin\" -> \"induces cytochrome P450\" -> \"decreases zidovudine levels\" -> \"reduced efficacy of HIV therapy\" -> 90%",
    "CHAIN: \"HIV positive patient\" -> \"on zidovudine, lamivudine, indinavir\" -> \"develops TB\" -> \"consider anti-tubercular drugs\" -> \"Rifampicin\" -> \"induces cytochrome P450\" -> \"drug interactions with protease inhibitors\" -> \"avoid Rifampicin\" -> 95%",
    "CHAIN: \"HIV positive patient\" -> \"on zidovudine, lamivudine, indinavir\" -> \"develops TB\" -> \"consider anti-tubercular drugs\" -> \"Pyrazinamide\" -> \"no significant interaction with HIV drugs\" -> \"safe to use\" -> 85%",
    "CHAIN: \"HIV positive patient\" -> \"on zidovudine, lamivudine, indinavir\" -> \"develops TB\" -> \"consider anti-tubercular drugs\" -> \"Isoniazid\" -> \"no significant interaction with HIV drugs\" -> \"safe to use\" -> 85%",
    "CHAIN: \"HIV positive patient\" -> \"on zidovudine, lamivudine, indinavir\" -> \"develops TB\" -> \"consider anti-tubercular drugs\" -> \"Ethambutol\" -> \"no significant interaction with HIV drugs\" -> \"safe to use\" -> 85%"
  ],
  "enhanced_information": "In HIV positive patients on zidovudine, lamivudine, and indinavir therapy who develop TB, Rifampicin is avoided due to its strong induction of cytochrome P450 enzymes, which significantly decreases the levels of indinavir and potentially zidovudine, leading to reduced efficacy of HIV therapy. In contrast, Pyrazinamide, Isoniazid, and Ethambutol do not have significant interactions with these HIV medications and are considered safe to use in this context. Therefore, the anti-tubercular drug that should be avoided is Rifampicin.",
  "analysis": "In HIV positive patients receiving antiretroviral therapy, particularly those on zidovudine, lamivudine, and indinavir, the choice of anti-tubercular drugs must consider potential drug interactions. Rifampicin is known to be a potent inducer of cytochrome P450 enzymes, which can significantly lower the plasma concentrations of indinavir, leading to reduced efficacy of the HIV treatment. This interaction poses a serious risk to the patient's health. In contrast, Pyrazinamide, Isoniazid, and Ethambutol do not have significant interactions with the mentioned HIV medications and can be safely used. Therefore, the anti-tubercular drug that should be avoided in this scenario is Rifampicin.",
  "answer": "opd",
  "confidence": 95.0,
  "chain_coverage": {
    "success_counts": [
      5,
      6,
      5,
      4,
      4,
      4
    ],
    "coverage_rates": [
      17.857142857142858,
      21.428571428571427,
      17.857142857142858,
      14.285714285714285,
      14.285714285714285,
      14.285714285714285
    ],
    "total_successes": 28
  },
  "normal_results": []
}